Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Clinical validity of NGS and innovation in clinical diagnosis

Milan Summit On Precision Medicine

Published: 21 Feb 2018

Views: 4626

Rating:

Save

Dr Jeffrey Ross - Albany Medical College, Albany, USA

Dr Jeffrey Ross presents at ecancer's Milan Summit on Precision Medicine 2018 about the uses and limitations of NGS in precision medicine.

He highlights important limiting factors and examples of mutations which require highly sensitive technology.

He also goes in to detail regarding the FoundationOne assay.

Overall, Dr Ross encourages the marrying of clinical and genomic data to drive discovery in cancer research.

The webcast has been supported by an unrestricted educational grant from Roche Foundation Medicine

Related Videos

Relapsed Refractory Multiple Myeloma

Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India

$Relapsed Refractory Multiple Myeloma ( Dr Hari Menon - St. Johns National Academy of Health Sciences, Bengaluru, India )$

Social determinants of health in primary care

Dr Jennifer Goldman - Memorial Healthcare System, Florida, USA

Social determinants of health in primary care ( Dr Jennifer Goldman - Memorial Healthcare System, Florida, USA )

Choosing Wisely in pathology

Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in pathology ( Dr Angela Mlole - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Choosing Wisely in radiology Tanzania

Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania

Choosing Wisely in radiology Tanzania ( Dr Revelian Iramu - Ocean Road Cancer Institute, Dar es Salaam, Tanzania )

Lung cancer screening and treatment in the Philippines

Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines

Lung cancer screening and treatment in the Philippines ( Dr Marcelo Severino Imasa - Lung Center of the Philippines, Manila, Philippines )

Molecular profiling in prostate cancer: key challenges for clinical...

Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain

Molecular profiling in prostate cancer: key challenges for clinical implementation ( Dr Joaquin Mateo - Vall d’Hebron Institute of Oncology, Barcelona, Spain )

Tumour-infiltrating lymphocyte treatment for advanced melanoma

Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands

Tumour-infiltrating lymphocyte treatment for advanced melanoma ( Dr John Haanen - Netherlands Cancer Institute, Amsterdam, Netherlands )

Breast cancer and survivorship

Dr. Ashwin Mehta - Memorial Healthcare System, Florida, USA

Breast cancer and survivorship ( Dr. Ashwin Mehta - Memorial Healthcare System, Florida, USA )

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial...

Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey

Using combined oral contraceptives may decrease risk of Ovarian, Endometrial and Colorectal cancer ( Dr Mustafa Kamani - Hacettepe University Faculty of Medicine, Ankara, Turkey )

More from ecancer